Skip to content
SEC Form 4insider transactionsfree

Merck & Co., Inc. insider buying and selling

5 Form 4 filings against Merck & Co., Inc. (MRK) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.

Window 2026-08-22 to 2026-11-20CIK 0000310158newest filing 2026-11-16source: SEC EDGAR, Form 4 XML
DateInsider and roleTransactionCodeSharesPriceOwned after
2026-11-12DeLuca Richard R.EVP&Pres, Merck Animal Heallthoption exerciseM58,185$77.62171,140
2026-11-12DeLuca Richard R.EVP&Pres, Merck Animal Heallthopen-market saleS58,185$148.01112,955

What the filings show

Across the 4 filings read here, 1 insider at Merck & Co., Inc. (MRK) filed; that insider reported 1 open-market sale of 58,185 shares worth about $8.6M.

The largest by value was DeLuca Richard R. (EVP&Pres, Merck Animal Heallth), with about $8.6M sold on the open market.

5 Form 4 filings were made against Merck & Co., Inc. in the 90 days to November 20, 2026; the paid report reads all of them.

Transaction codes: P is an open-market purchase, S an open-market sale, A a grant or award, M an option exercise, F shares surrendered for tax. 0 open-market buys and 1 open-market sale in the rows above.
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The Form 4 flow against Merck & Co., Inc., parsed and explained

The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.

agents: POST /v1/insider-report with {"ticker":"MRK"} over x402 or MPP, $0.60

Sample output and API docsall reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.